Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q1 FY26 Earnings Presentation
21 slides from Aarti Industries's earnings presentation, Jul 31, 2025
Slide 1: Results Presentation cover letter to exchanges
July 31, 2025 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD. National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai – 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051. BSE CODE : 524208
Slide 2: Q1FY26 Performance Update: Resilient Today, Promising Tomorrow
Q1FY26 Performance Update Resilient Today 31 July 2025 Promising Tomorrow
Slide 3: Disclaimer
2 Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does no
Slide 4: Index
Index 1 Company overview 2 Q1FY26 Highlights 3 Future Outlook and Roadmap
Slide 5: Index
Index 1 Company overview 2 Q1FY26 Highlights 3 Future Outlook and Roadmap
Slide 6: Aarti Industries at a Glance
5 Aarti Industries at a Glance Toluene based Sulphuric Acid Downstream Products Products ● Established by first generation technocrats in 1984 Benzene based Speciality Other Speciality ● Integrated operations and high-cost optimization Downstream Chemicals Chemicals ● Key value chains include Nitro
Slide 7: Our Ethos
6 Our Ethos PURPOSE Right Chemistry for AIL VALUES a Brighter Tomorrow CARE VISION To emerge as a Global Partner of Choice for leading consumers of INTEGRITY speciality chemicals and intermediates MISSION Delighted Stakeholders EXCELLENCE
Slide 8: Index
Index 1 Company overview 2 Q1FY26 Highlights 3 Future Outlook and Roadmap
Slide 9: Business Highlights
8 Business Highlights MMA capacity expansion completed to 260 kTPA with further potential to expand at incremental CAPEX. DCB volumes declined due to demand concerns, while PDA volumes saw uptick on account of favourable tariffs for US markets. Growth Capex: Zone-4 projects execution progressing as
Slide 10: Q1 FY26 Highlights (Consolidated)
9 Q1 FY26 Highlights (Consolidated) ₹ in Cr YoY : 7% ▼ YoY : 31% ▼ YoY : 69% ▼ QoQ: 16% ▼ QoQ: 19% ▼ QoQ: 55% ▼ ● Revenue declined due to - Reduction in key RM prices - Postponement of few bulk shipments from June to July ● Non-Energy Business Volumes: – YoY: 9%▲ ‒ QoQ: 4%▼ Q1FY25 Q4FY25 Q1FY26 Q1FY
Slide 11: Capacities and utilization trend for few major products
10 Capacities and utilization trend for few major products Capacity FY25 Q1 FY25 Q4 FY25 Q1 FY26 Y-o-Y FY26 Q1 Product Groups Q-o-Q (in KTPA) (kT) (kT) (kT) (kT) Q1 Utilization% NCB 108 85.3 19.5 23.9 21.7 -9% 11% 80% DCB 120 88.6 24.1 20.4 19.3 -5% -20% 64% Hydrogenation 60 44.4 10.3 11.6 12.3 6% 1
Slide 12: Revenue by End Use
11 Revenue by End Use ₹ Cr 8079 2008 2214 1867 ● End-use application mix is broadly Agrochemicals & 18% 20% 19% 18% similar to last years end-use mix Fertilizers 12% ● Energy end application getting Dyes, Pigments and 14% 12% 15% Printing Inks stabilized driven by higher volumes but lower margins du
Slide 13: Application wise market updates & business highlights (1/2)
12 Application wise market updates & business highlights (1/2) End Use Agrochemical & Fertilizers Energy & Additives Chloro Anilines, Di Chloro Phenols, Ethylated & Key Products MMA, CaCl2 Fluorinated products Revenue Share1 18% 36% Domestic Export Domestic Export Domestic / Exports1 78% 22% 13% 87%
Slide 14: Application wise market updates & business highlights (2/2)
13 Application wise market updates & business highlights (2/2) End Use Dyes, Pigments & Printing Inks Pharmaceuticals Polymer and additives PNCB, MDCB & Fluorinated Key Products NCBs, DCBH, PNT PDCB, MPDA, ONA compounds Revenue Share1 15% 12% 14% Domestic Export Domestic Export Domestic Export Domes
Slide 15: Joint Ventures
14 Joint Ventures Augene Chemical Private Limited Re Aarti Private Limited ● Joint venture for manufacturing and ● Focus on Chemical recycling of plastics marketing of specialty chemicals with ● Resource recovery capacity of 500 TPD is multiple downstream applications targeted by 2030 ● Combines the
Slide 16: Index
15 Index 1 Company overview 2 Q1FY26 Highlights 3 Future Outlook and Roadmap
Slide 17: Key EBITDA Growth Drivers in near term (FY26 - FY28)
✔ Completed 16 Key EBITDA Growth Drivers in near term (FY26 - FY28) ✔ Partially Completed Initiated - execution in progress ✔ Switching to BPT¹ to improve Cogen Cost Optimisation Renewable Power phase 2 ✔ Waste energy streams utilization, ETP cost optimisation ✔ Fixed cost optimization ₹ 150-200 Cr
Slide 18: Growth Outlook - consistent with previous update
17 Growth Outlook - consistent with previous update Core YTD EBITDA Contract-1 Cancellation Projected Annual EBITDA Consistent volume growth over 3 yrs driven by increased capacities EBITDA for FY25 in line with the estimate of 1800 - 2200 ₹1000-1050 crs given for the year Operating leverages and co
Slide 19: Long term growth focus areas
18 Long term growth focus areas MPP and Zone 4 Commercialization ● R&D and MPP will support quick development, qualification and commercialization of new advanced chemistries ● Chlorotoluene commissioning and ramp up will open up new opportunities in Agro and Pharma business segments New Growth Aven
Slide 20: Certifications
19 Certifications The certifications listed above may be applicable to only some manufacturing units of Aarti Industries
Slide 21: Thank You
Thank You +91 22 67976666 investorrelations@aarti-industries.com